MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 45, November 14, 2024

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023–June 2024 / Brian Lefferts et al
  
  Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications — United States, 2023–2024 / Aaron M. Frutos et al
  
  Pediatric Rash Illness Outbreak with Initial Positive Measles Immunoglobulin M Antibody Test Results — American Samoa, March–July 2023 / Ruth Stefanos et al
  
  Progress Toward Measles Elimination — Worldwide, 2000–2023 / Anna A. Minta et all
  
  
• Subjects:
  Disease Notification Public Health Public Health Surveillance
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 45
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Document Type:
  Journal Issue
• Genre:
  Tables ; Statistics
• Place as Subject:
  United States
• Pages in Document:
  29 pdf pages
• Volume:
  73
• Issue:
  45
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:0093c2ee9df753c7070e76b04a287819aabb836f16af05055ec8800909f9911e203898343af9388d094d7e70192fe698ae1b5aff4cf97c6dc07d4568bf575860
• Download URL:
  https://stacks.cdc.gov/view/cdc/169937/cdc_169937_DS1.pdf
• File Type:
  [PDF - 2.14 MB ]